Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2
Stephen M. Kissler, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Mallery I. Breban, Anne E. Watkins, Radhika M. Samant, Deverick J. Anderson, David D. Ho, Nathan D. Grubaugh, View ORCID ProfileYonatan H. Grad
doi: https://doi.org/10.1101/2021.02.16.21251535
Stephen M. Kissler
1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA
Joseph R. Fauver
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
Christina Mack
3IQVIA, Real World Solutions, Durham, NC
4Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, NC
Caroline G. Tai
3IQVIA, Real World Solutions, Durham, NC
Mallery I. Breban
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
Anne E. Watkins
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
Radhika M. Samant
3IQVIA, Real World Solutions, Durham, NC
Deverick J. Anderson
5Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC
David D. Ho
6Aaron Diamond AIDS Research Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY
Nathan D. Grubaugh
2Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT
Yonatan H. Grad
1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA
Article usage
Posted February 19, 2021.
Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2
Stephen M. Kissler, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Mallery I. Breban, Anne E. Watkins, Radhika M. Samant, Deverick J. Anderson, David D. Ho, Nathan D. Grubaugh, Yonatan H. Grad
medRxiv 2021.02.16.21251535; doi: https://doi.org/10.1101/2021.02.16.21251535
Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2
Stephen M. Kissler, Joseph R. Fauver, Christina Mack, Caroline G. Tai, Mallery I. Breban, Anne E. Watkins, Radhika M. Samant, Deverick J. Anderson, David D. Ho, Nathan D. Grubaugh, Yonatan H. Grad
medRxiv 2021.02.16.21251535; doi: https://doi.org/10.1101/2021.02.16.21251535
Subject Area
Subject Areas
- Addiction Medicine (395)
- Allergy and Immunology (707)
- Anesthesia (198)
- Cardiovascular Medicine (2903)
- Dermatology (249)
- Emergency Medicine (435)
- Epidemiology (12665)
- Forensic Medicine (10)
- Gastroenterology (818)
- Genetic and Genomic Medicine (4520)
- Geriatric Medicine (411)
- Health Economics (722)
- Health Informatics (2890)
- Health Policy (1061)
- Hematology (381)
- HIV/AIDS (917)
- Medical Education (419)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4280)
- Nursing (231)
- Nutrition (630)
- Oncology (2244)
- Ophthalmology (639)
- Orthopedics (257)
- Otolaryngology (324)
- Pain Medicine (274)
- Palliative Medicine (83)
- Pathology (492)
- Pediatrics (1188)
- Primary Care Research (491)
- Public and Global Health (6865)
- Radiology and Imaging (1509)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (379)
- Surgery (478)
- Toxicology (60)
- Transplantation (206)
- Urology (177)